ERIC GILL: Open Payments
NPI 1669859740 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 8 payments from 5 companies in 2025. Trend: 2023 $123 · 2024 $248 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $355 |
| Alexion Pharmaceuticals, Inc. | 2 | $254 |
| Novo Nordisk Inc | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Genentech USA, Inc. | 1 | $122 |
Products named: REZDIFFRA, ULTOMIRIS, Wegovy, REXULTI, Xolair.
Industry payments across NC — which companies pay providers there.
